These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 17895357)

  • 1. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation.
    Hasselblatt P; Drognitz K; Potthoff K; Bertz H; Kruis W; Schmidt C; Stallmach A; Schmitt-Graeff A; Finke J; Kreisel W
    Aliment Pharmacol Ther; 2012 Oct; 36(8):725-35. PubMed ID: 22937722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
    Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
    Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease.
    Clerici M; Cassinotti A; Onida F; Trabattoni D; Annaloro C; Della Volpe A; Rainone V; Lissoni F; Duca P; Sampietro G; Fociani P; Vago G; Foschi D; Ardizzone S; Deliliers GL; Porro GB
    Dig Liver Dis; 2011 Dec; 43(12):946-52. PubMed ID: 21907652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation.
    Kreisel W; Potthoff K; Bertz H; Schmitt-Graeff A; Ruf G; Rasenack J; Finke J
    Bone Marrow Transplant; 2003 Aug; 32(3):337-40. PubMed ID: 12858208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
    Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
    J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
    Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells as treatment in inflammatory bowel disease.
    Hawkey CJ
    Dig Dis; 2012; 30 Suppl 3():134-9. PubMed ID: 23295704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
    Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
    Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.
    Rabusin M; Andolina M; Maximova N; Lepore L; Parco S; Tuveri G; Jankovic G
    Haematologica; 2000 Nov; 85(11 Suppl):81-5. PubMed ID: 11268330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
    Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J
    Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.
    D'Haens G; Swijsen C; Noman M; Lemmens L; Ceuppens J; Agbahiwe H; Geboes K; Rutgeerts P
    Am J Gastroenterol; 2001 Sep; 96(9):2564-8. PubMed ID: 11569676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients.
    Carreras E; Saiz A; Marín P; Martínez C; Rovira M; Villamor N; Aymerich M; Lozano M; Fernández-Avilés F; Urbano-Izpizua A; Montserrat E; Graus F
    Haematologica; 2003 Mar; 88(3):306-14. PubMed ID: 12651270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide-free Mobilisation Increases Safety While Preserving the Efficacy of Autologous Haematopoietic Stem Cell Transplantation in Refractory Crohn's Disease Patients.
    Giordano A; Rovira M; Veny M; Barastegui R; Marín P; Martínez C; Fernández-Avilés F; Suárez-Lledó M; Domènech A; Serrahima A; Lozano M; Cid J; Ordás I; Fernández-Clotet A; Caballol B; Gallego M; Vara A; Masamunt MC; Giner À; Teubel I; Esteller M; Corraliza AM; Panés J; Salas A; Ricart E
    J Crohns Colitis; 2024 Oct; 18(10):1701-1712. PubMed ID: 38757210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.
    Lindsay JO; Allez M; Clark M; Labopin M; Ricart E; Rogler G; Rovira M; Satsangi J; Farge D; Hawkey CJ; ; ;
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):399-406. PubMed ID: 28497755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.